Cornerstone Capital Management’s Gilead Sciences GILD Stock Holding History

Cornerstone Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$22.6M	Sell	285,267 -542,056	-66%	-$44M	3.56%	6
2016 Q2	$69M	Buy	827,323 +112,396	+16%	+$9.97M	3.65%	6
2016 Q1	$65.7M	Buy	714,927 +54,287	+8%	+$4.9M	2.87%	13
2015 Q4	$66.8M	Buy	660,640 +85,335	+15%	+$8.88M	2.73%	14
2015 Q3	$56.5M	Sell	575,305 -116,424	-17%	-$12.9M	2.4%	18
2015 Q2	$81M	Sell	691,729 -13,679	-2%	-$1.49M	2.66%	13
2015 Q1	$69.2M	Buy	705,408 +73,803	+12%	+$7.49M	2.28%	21
2014 Q4	$59.5M	Buy	+631,605	New	+$65.3M	1.93%	28
2014 Q3	–	Sell	-1,156,372	Closed	-$95.9M	–	48
2014 Q2	$95.9M	Sell	1,156,372 -43,770	-4%	-$3.41M	3.07%	9
2014 Q1	$85M	Buy	1,200,142 +243,913	+26%	+$19.1M	2.76%	11
2013 Q4	$71.8M	Sell	956,229 -233,916	-20%	-$16.3M	2.13%	22
2013 Q3	$74.8M	Sell	1,190,145 -11,936	-1%	-$713K	2.31%	16
2013 Q2	$61.6M	Buy	+1,202,081	New	+$62.7M	2.03%	22

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management's GILD Position: Q3 2016 in Review

Cornerstone Capital Management reduced its Gilead Sciences (GILD) stake by 66% in Q3 2016, selling an estimated $44M and leaving 285,267 shares worth $22.6M. The position accounts for 3.56% of the portfolio, ranked #6.

Cornerstone Capital Management first reported a position in GILD in Q2 2013 and has held it in 13 quarters since. The position peaked at $95.9M in Q2 2014. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Cornerstone Capital Management held 285,267 shares of Gilead Sciences worth $22.6M as of Q3 2016.
Cornerstone Capital Management sold 542,056 Gilead Sciences shares in Q3 2016, an estimated $44M.
Gilead Sciences made up 3.56% of Cornerstone Capital Management's portfolio in Q3 2016, its #6 holding.
Cornerstone Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 13 quarters since.
Cornerstone Capital Management's Gilead Sciences position peaked at $95.9M in Q2 2014.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Cornerstone Capital Management's 13F filing for Q3 2016, filed 3 Nov 2016.